Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31636159 | 0.98 | TSHR (0.59) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL870590 | 0.98 | TSHR (0.59) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL31636173 | 0.98 | TSHR (0.59) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL31636152 | 0.98 | TSHR (0.59) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL3503120 | 0.98 | TSHR (0.59) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL8523214 | 0.95 | TSHR (0.53) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL4640880 | 0.93 | TSHR (0.56) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL24963 | 0.87 | TSHR (0.52) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL28572398 | 0.87 | FAAH (0.46) | TSHRTHRBFAAHALDH1A1CNR1 | |
| 1,6-Hexanediol SCHEMBL14343519 | 0.86 | TSHR (0.53) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250212659-A1 | ENCAPSULATING COMPOSITION FOR ORGANIC LIGHT EMITTING DIODE AND DEVICE THEREFROM | DUK SAN NEOLUX CO., LTD. (KR) | 2025-06-26 | — | — | US | claimed |
| US-5098696-A | Methacrylate monomers for polymers with tert-amine promoters and di or trimethacrylate monomers and peroxide catalysts | REM SYSTEMS, INC. (US) | 1992-03-24 | — | — | US | claimed |
| US-4871534-A | METHACRYLATE BINDER, METHACRYLATE POLYMER, PEROXIDE INITIATOR | REM SYSTEMS, INC. (US) | 1989-10-03 | — | — | US | claimed |
| US-20250212659-A1 | ENCAPSULATING COMPOSITION FOR ORGANIC LIGHT EMITTING DIODE AND DEVICE THEREFROM | DUK SAN NEOLUX CO., LTD. (KR) | 2025-06-26 | — | — | US | disclosed |
| US-20250155808-A1 | RESIST COMPOSITION AND METHOD OF FORMING RESIST PATTERN | ZEON CORPORATION (JP) | 2025-05-15 | — | — | US | disclosed |
| WO-2024143072-A1 | COMPOSITION AND CURED PRODUCT | 株式会社ADEKA | 2024-07-04 | — | — | WO | disclosed |
| WO-2024070672-A1 | RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN | 日本ゼオン株式会社 | 2024-04-04 | — | — | WO | disclosed |
| WO-2023189969-A1 | RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN | 日本ゼオン株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-3932906-B1 | NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, AND CURED OBJECT | ADEKA CORP (JP) | 2023-07-12 | — | — | EP | disclosed |
| US-11667609-B2 | Compound, composition containing said compound, self-healing material, surface coating agent, paint, adhesive, material for battery and cured product | ADEKA CORPORATION (JP) | 2023-06-06 | — | — | US | disclosed |
| CN-113544120-B | Novel compound, composition containing same, self-repairing material, surface coating agent, paint, adhesive, battery material, and cured product | 株式会社ADEKA | 2023-05-02 | — | — | CN | disclosed |
| US-4866148-A | CROSSLINKED VINYLPYRROLIDONE, METHYLVINYLACETAMIDE, METHACRYLIC ACID ESTER | BAYER AKTIENGESELLSCHAFT (DE) | 1989-09-12 | — | — | US | disclosed |
| US-4861832-A | Flexible epoxy film from an epoxy resin reacted with a ketimine/amine terminated butadiene/acrylonitrile copolymer blend | LORD CORPORATION (US) | 1989-08-29 | — | — | US | disclosed |
| EP-0184729-B1 | SOFT CONTACT LENSES | BAYER AG (DE) | 1989-08-09 | — | — | EP | disclosed |
| EP-0186789-B1 | HYDROPHILIC COPOLYMERS, THEIR USE AS BIOMEDICAL MATERIALS AND CONTACT LENSES MADE OF THESE COPOLYMERS | BAYER AG (DE) | 1989-06-28 | — | — | EP | disclosed |
| US-4703097-A | N-VINYLCARBOXAMIDE, (METH)ACRYLATES OF POLYSILOXANES AND UNSATURATED COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1987-10-27 | — | — | US | disclosed |
| EP-0241796-A2 | Composition for contact lenses | Geyer, Otto-Christian, Dr. (DE) | 1987-10-21 | — | — | EP | disclosed |
| EP-0186789-A2 | Hydrophilic copolymers, their use as biomedical materials and contact lenses made of these copolymers | BAYER AG (DE) | 1986-07-09 | — | — | EP | disclosed |
| EP-0184727-A2 | Soft contact lenses with poor hydrophilic properties | BAYER AG (DE) | 1986-06-18 | — | — | EP | disclosed |
| EP-0184729-A2 | Soft contact lenses | BAYER AG (DE) | 1986-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667609-B2 | Compound, composition containing said compound, self-healing material, surface coating agent, paint, adhesive, material for battery and cured product | H1-0, H1-10, RAD51 | TSHR 4534/4885THRB 3173/4885POLB 1026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.